Past CureTalks
HIFU for Prostate Cancer Finally Gets the FDA Nod. What to expect.
After more than 10 years of clinical trials, the Food and Drug Administration on October 9 approved the first high-intensity focused ultrasound (HIFU) device for ablation of prostate tissue. HIFU has already been approved for use in prostate tissue outside…
Psychosocial and Emotional Aspects of Infertility and Infant Loss (Part II)
Psychotherapist Helen Adrienne is back on CureTalks to discuss how mind-body therapies can help heal and overcome the emotional trauma usually associated with infertility. In the previous episode, the panel discussed how tested mind-body techniques can help with the guilt and…
Role of Allogeneic Stem Cell Transplant in Myeloma Treatment with Dr. Krishna Komanduri
The role of allogeneic stem-cell transplantation is evolving in the paradigm of myeloma treatment. Despite its therapeutic potential of a myeloma cure, the use of donor stem cell transplantation is highly debated in the medical field due to the safety…
Understanding Multiple Myeloma: Types of Diagnostic Tests and Frequency
Myeloma presents itself differently in each patient. In order to understand your Myeloma and monitor it, you need to know which are the tests available and how often you have to get tested. No single test or study is adequate…
Patient Advocates: Their Role and Benefits in Clinical Trial Groups
September is Prostate Cancer Awareness month and we are talking to patient advocates to get a better insight into their roles in major clinical groups. Mike Scott is talking to Tony Crispino, patient advocate to the Genitourinary Cancer Section of…